Fractyl Health (GUTS) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

GUTS Fractyl Health

Watchlist

2.280
-0.240-9.52%

Close Dec 11 16:00 ET

2.300
+0.020+0.88%

Post 20:01 ET

109.67MMarket Cap-1.59P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Fractyl Health to Present New Preclinical Data From Its Rejuva Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)
GlobeNewswireDec 9 07:00 ET
Fractyl Health to Participate in the Upcoming December Conferences
GlobeNewswireNov 26 07:00 ET
Fractyl Health Management to Meet Virtually With B. Riley
TipRanksNov 19 11:50 ET
Fractyl Health, Inc. (GUTS) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 14 23:39 ET · Conference Call
BofA Securities Maintains Fractyl Health(GUTS.US) With Buy Rating
Moomoo NewsNov 13 10:33 ET · Ratings
Fractyl Health's Strategic Advancements and Promising Data Drive Buy Rating
TipRanksNov 13 05:41 ET · Ratings

Comments

Trytosaveabit

Dec 9 06:27

On watch for data release! Note the dates this week!

$Fractyl Health (GUTS.US)$ BURLINGTON, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced it will present new preclinical data from its Rejuva platform at the 2024 Poster Session of the 22nd World Congress Insulin Resistance, Diabetes & Cardiovascular Disease...

Trytosaveabit

Nov 4 15:20

Update

$Fractyl Health (GUTS.US)$ Fractyl Health: Results Show Sustained Maintenance of Weight Loss, Blood Sugar Levels at Week 13 in Dio Mice Given Rjva-001 & Continuing High Fat Diet

Jaguar8

Oct 28 22:17

Mark calendar. Presentation Nov 3 & 5 obesity related.

$Fractyl Health (GUTS.US)$
Oral Presentation
Title: Islet-Targeted GLP-1 Receptor Agonist Gene Therapy Reduces Fat and Improves Metabolism in Obese Mice
Presentation Date & Time: Tuesday, November 5, 2024, 10:45 am - 11:00 am (CDT)
Location: Henry B. Gonzalez Convention Center, Room 007
Poster Presentation
Title: Duodenal Mucosal Resurfacing Durably Maintains Weight Loss in Metabolic Disease
Presentation Date & Time: Sunday, November 3, 2024,...

Stock_Drift

Oct 28 10:08

Unusual Volume Ticks. 11:07am 10/28

$Fractyl Health (GUTS.US)$ $Pixie Dust Technologies(Delisted) (PXDT.US)$ $Oklo Inc (OKLO.US)$ $Revance Therapeutics (RVNC.US)$ $PROCEPT BioRobotics (PRCT.US)$ $Atlas Lithium (ATLX.US)$ $EyePoint Pharmaceuticals (EYPT.US)$ $Porch Group (PRCH.US)$ $Top Wealth Group Holding (TWG.US)$ $Global Mofy AI (GMM.US)$ $Monte Rosa Therapeutics (GLUE.US)$ $Evoke Pharma (EVOK.US)$ $Greenlane (GNLN.US)$ $Autonomix Medical (AMIX.US)$ $Healthcare Triangle (HCTI.US)$
📊⚡️📊

Trytosaveabit

Oct 28 06:04

Watching

$Fractyl Health (GUTS.US)$ Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
2 MINUTES AGO, 7:00 AM EDT
VIA GLOBENEWSWIRE
BURLINGTON, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (NASDAQ:GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced that it will present compelling weight maintena...

Heat List

Overall

No Data